Is Ampio Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Ampio Pharmaceuticals Inc (AMPE) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Ampio Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ampio Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Ampio Pharmaceuticals Inc?

Muslim investors may consider investing in Ampio Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ampio Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Ampio Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ampio Pharmaceuticals Inc updated?

The Shariah compliance status of Ampio Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ampio Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ampio Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Ampio Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AMPE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 27, 2024

Report Source: 2023 Annual Report

Analyst's Ratings for Ampio Pharmaceuticals Inc (AMPE)

Based on 6 analysts giving stock ratings to Ampio Pharmaceuticals Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Ampio Pharmaceuticals Inc. Stock Analysis AMPE

United States Health Care Nano Cap Report: 2023 Annual

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Key Statistics of Ampio Pharmaceuticals Inc (AMPE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.18$0.18

Today's Open

$0.18

Volume

372.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.64

Market Cap

5903.90

Avg. Volume

373.30

Dividend Yield

Financial Metrics & Statements of Ampio Pharmaceuticals Inc (AMPE)

FAQ's for Ampio Pharmaceuticals Inc (AMPE)

According to Musaffa’s Shariah screening methodology, Ampio Pharmaceuticals Inc (AMPE) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.